The in vivo results using intravenously injected glioma-bearing mice were also in agreement with the previous evidence, since the mice treated with mannose-coated HSA nanoparticles displayed a reduction in tumor size, when compared to animals treated with uncoated HSA nanoparticles [46]. The gene discussed is ALB; the disease is neoplasm.